{"key":"op_1423_KR","page":{"url":"https://us-uk.bookimed.com/clinics/country=republic-of-korea/procedure=stem-cell-therapy-for-copd/","procedure":{"id":1423,"slug":"stem-cell-therapy-for-copd","name":"Stem cell therapy for COPD","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"stem-cells","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":36,"iso":"KR","name":"Republic of Korea"},"currency":"USD","data_date":"2026-09-29"},"pages":{"clinics_url":"https://us-uk.bookimed.com/clinics/country=republic-of-korea/procedure=stem-cell-therapy-for-copd/","cost_url":"https://us-uk.bookimed.com/clinics/country=republic-of-korea/procedure=stem-cell-therapy-for-copd/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":9000,"to":20000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":6500,"to":12500},"uk":{"from":7500,"to":14500},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Cheonan","from":11800},{"city":"Seoul","from":9000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":11100,"to":13300},{"country_iso":"FR","from":4500,"to":9500},{"country_iso":"GB","from":7500,"to":14500},{"country_iso":"US","from":6500,"to":12500},{"country_iso":"IL","from":12000,"to":20000},{"country_iso":"TR","from":6500,"to":11000},{"country_iso":"MX","from":6500,"to":12500},{"country_iso":"DE","from":6500,"to":13500},{"country_iso":"CA","from":7500,"to":15000},{"country_iso":"AE","from":9500,"to":19000},{"country_iso":"TH","from":13300,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"PL","from":4500,"to":8500},{"country_iso":"CZ","from":12000,"to":18000},{"country_iso":"AT","from":9500,"to":15500},{"country_iso":"ES","from":6500,"to":11000},{"country_iso":"IT","from":18000,"to":30000},{"country_iso":"CN","from":9000,"to":20000},{"country_iso":"AU","from":7500,"to":15000},{"country_iso":"IN","from":4500,"to":8500},{"country_iso":"MY","from":6500,"to":12500},{"country_iso":"VN","from":6500,"to":12500},{"country_iso":"BR","from":7500,"to":12500},{"country_iso":"CO","from":5500,"to":8500}],"base_country":"US","base_is_fallback":false},"savings":{"pct":-38,"variant":"ranges_overlap"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":1,"items":[{"id":6541,"name":"RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)","city":"Cheonan","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Korean Institute for Healthcare Accreditation","Best clinic for patients with rare diseases"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":{"status":"missing","reason":"not_collected"},"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":1627,"slug":"cheonan","name":"Cheonan","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":11800,"profile":{"status":"missing","reason":"not_collected"}},{"id":328,"slug":"seoul","name":"Seoul","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9000,"profile":{"city_type":"Capital of Republic of Korea","access":["Incheon Airport (ICN), 48 km west of Seoul","Gimpo Airport (GMP), 15 km west of central Seoul"],"sources":["https://en.wikipedia.org/wiki/Seoul","https://en.wikipedia.org/wiki/Incheon_International_Airport","https://en.wikipedia.org/wiki/Gimpo_International_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Stable moderate to severe COPD","Persistent breathlessness despite optimized inhaled therapy"],"contraindications":["Active infection","Current or recent cancer","Severe heart failure or unstable cardiac disease","Pregnancy or breastfeeding","Uncontrolled bleeding disorder","Acute COPD exacerbation","Severe respiratory failure","Immunosuppression or active autoimmune disease"],"operation_hours":{"min":3,"max":6,"unit":"hours","qualifier":"Collection and infusion visit time; off-site culture expansion not included."},"anesthesia":["local"],"sessions_or_stages":{"sessions":{"min":1,"max":2,"unit":"visits","qualifier":"One visit for same-day concentrate; culture-expanded cells need two."},"stages":[{"code":"cell_collection","label":"Cell collection from bone marrow or fat","after":{"min":0,"max":0,"unit":"days","qualifier":"Day of treatment"}},{"code":"cell_processing","label":"Cell processing; culture expansion where used","after":{"min":0,"max":28,"unit":"days","qualifier":"Same day for concentrates; about 2-4 weeks if expanded"}},{"code":"cell_infusion","label":"Intravenous cell infusion","after":{"min":0,"max":35,"unit":"days","qualifier":"Same day for concentrates; 2-5 weeks after collection if expanded"}}],"qualifier":"Concentrates fit one stay; culture-expanded cells need a return for infusion."},"hospital_nights":{"value":{"min":4,"max":7,"unit":"nights","qualifier":"Single stay for same-day concentrates, including post-infusion observation."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":3,"max":7,"unit":"days","qualifier":"Time to ordinary daily function; pulmonary rehabilitation exercises may continue longer at home."},"fly_home_after_days":{"min":4,"max":7,"unit":"days","qualifier":"After post-infusion observation, with stable oxygen saturation and clearance for in-flight oxygen needs."},"back_to_work_days":{"min":2,"max":7,"unit":"days","qualifier":"Depends on cell source collection method and baseline COPD severity; desk work resumes sooner."},"exercise_resume_weeks":{"min":1,"max":4,"unit":"weeks","qualifier":"Light activity first; return to usual exercise depends on COPD severity and collection site healing."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Any reported symptom change is gradual; benefit is unproven and varies with disease stage and cell product."},"result_longevity":"Durability is unproven; any symptomatic benefit is typically modest and may fade within 6-12 months. COPD progression continues.","main_risks":["Unknown long-term safety","Possible infusion reactions, infection, or procedure complications.","Unregulated products may be contaminated or mislabeled."],"complication_rate_pct":{"min":5,"max":20,"unit":"percent","qualifier":"Mostly mild transient events (fever, fatigue, site pain) within 30 days; serious events rare in trials."},"revision_rate_pct":{"min":5,"max":15,"unit":"percent","qualifier":"Share of patients needing a repeat infusion course."},"success":{"metric":{"status":"missing","reason":"not_collected"},"value":{"status":"missing","reason":"not_collected"},"horizon":{"status":"missing","reason":"not_collected"},"source":{"status":"missing","reason":"not_collected"},"evidence_status":"not_proven"},"scars":"No visible scarring from intravenous infusion; a tiny mark may remain at the bone marrow or fat collection site.","pain":"Mild discomfort at the collection or venous access site, treated with simple analgesics. Infusion itself is usually painless; transient fever or fatigue may occur.","preparation":["Send spirometry, chest CT and blood gas results","Pulmonologist review of COPD stage and stability","Review blood thinners with physician before collection","Continue usual inhalers and oxygen therapy","Pre-procedure blood tests and infection screening","Avoid smoking before and after treatment"],"recovery_timeline":[{"phase":"Day 0-1","description":"Cell collection; same-day infusion for concentrates with reaction monitoring. Mild fatigue or low-grade fever possible.","restrictions":["Rest after infusion"]},{"phase":"Days 2-7","description":"Collection site settles; breathing monitored and routine medications continued.","restrictions":["No heavy lifting","Avoid crowds and infection exposure"]},{"phase":"Weeks 2-4","description":"Gradual return to normal activity and supervised light exercise.","restrictions":["Avoid strenuous exertion","No smoking"]},{"phase":"Months 3-6","description":"Reassessment of lung function and symptoms; benefit, if any, appears gradually.","restrictions":{"status":"missing","reason":"not_collected"}}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":30,"max":90,"unit":"days","qualifier":"Spirometry, symptom and oxygen review, often remote or with home pulmonologist."}},{"purpose":"result_review","requirement":"routine","after":{"min":150,"max":210,"unit":"days","qualifier":"Repeat spirometry, 6-minute walk test and quality-of-life review."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check whether the treatment is marketed as approved for COPD","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes","host":"fda.gov","quote":"None of these products have been approved for the treatment of any cardiovascular or pulmonary (lung) diseases, such as heart disease, emphysema, or chronic obstructive pulmonary disease (COPD).","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that you understand the entire process and known risks before signing","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Make sure you understand the entire process and known risks before you sign.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check whether the treatment has been reviewed by the relevant medical authority","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Ask if the FDA has reviewed the treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Check whether the clinic provides the clinical-trial authorization number and related agency communication","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Ask the clinical investigator to give you the FDA-issued Investigational New Drug Application (IND) number and the chance to review the FDA communication acknowledging the IND.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Clinic claims the product is safe and effective though it is not adequately studied","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies","host":"fda.gov","quote":"These regenerative medicine products have risks but are often illegally marketed by clinics as being safe and effective for the treatment of a wide range of diseases or conditions, even though they haven’t been adequately studied under an IND to demonstrate the claims of safety and effectiveness.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"An offer claims stem-cell products are approved for COPD","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes","host":"fda.gov","quote":"None of these products have been approved for the treatment of any cardiovascular or pulmonary (lung) diseases, such as heart disease, emphysema, or chronic obstructive pulmonary disease (COPD).","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-13","next_check_at":"2027-02-11"},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["local"],"back_to_work_days":{"min":2,"max":7,"unit":"days","qualifier":"Depends on cell source collection method and baseline COPD severity; desk work resumes sooner."},"complication_rate_pct":{"min":5,"max":20,"unit":"percent","qualifier":"Mostly mild transient events (fever, fatigue, site pain) within 30 days; serious events rare in trials."},"contraindications":["Active infection","Current or recent cancer","Severe heart failure or unstable cardiac disease","Pregnancy or breastfeeding","Uncontrolled bleeding disorder","Acute COPD exacerbation","Severe respiratory failure","Immunosuppression or active autoimmune disease"],"days_in_clinic":{"min":4,"max":7,"unit":"nights","qualifier":"Single stay for same-day concentrates, including post-infusion observation."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":1,"max":4,"unit":"weeks","qualifier":"Light activity first; return to usual exercise depends on COPD severity and collection site healing."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Any reported symptom change is gradual; benefit is unproven and varies with disease stage and cell product."},"fly_home_after_days":{"min":4,"max":7,"unit":"days","qualifier":"After post-infusion observation, with stable oxygen saturation and clearance for in-flight oxygen needs."},"follow_up_visits":[{"purpose":"assessment","after":{"min":30,"max":90,"unit":"days","qualifier":"Spirometry, symptom and oxygen review, often remote or with home pulmonologist."},"requirement":"routine"},{"purpose":"result_review","after":{"min":150,"max":210,"unit":"days","qualifier":"Repeat spirometry, 6-minute walk test and quality-of-life review."},"requirement":"routine"}],"indications":["Stable moderate to severe COPD","Persistent breathlessness despite optimized inhaled therapy"],"main_risks":["Unknown long-term safety","Possible infusion reactions, infection, or procedure complications.","Unregulated products may be contaminated or mislabeled."],"pain":"Mild discomfort at the collection or venous access site, treated with simple analgesics. Infusion itself is usually painless; transient fever or fatigue may occur.","preparation":["Send spirometry, chest CT and blood gas results","Pulmonologist review of COPD stage and stability","Review blood thinners with physician before collection","Continue usual inhalers and oxygen therapy","Pre-procedure blood tests and infection screening","Avoid smoking before and after treatment"],"recovery_timeline":[{"phase":"Day 0-1","description":"Cell collection; same-day infusion for concentrates with reaction monitoring. Mild fatigue or low-grade fever possible.","restrictions":["Rest after infusion"]},{"phase":"Days 2-7","description":"Collection site settles; breathing monitored and routine medications continued.","restrictions":["No heavy lifting","Avoid crowds and infection exposure"]},{"phase":"Weeks 2-4","description":"Gradual return to normal activity and supervised light exercise.","restrictions":["Avoid strenuous exertion","No smoking"]},{"phase":"Months 3-6","description":"Reassessment of lung function and symptoms; benefit, if any, appears gradually.","restrictions":[]}],"rehabilitation_days":{"min":3,"max":7,"unit":"days","qualifier":"Time to ordinary daily function; pulmonary rehabilitation exercises may continue longer at home."},"result_longevity":"Durability is unproven; any symptomatic benefit is typically modest and may fade within 6-12 months. COPD progression continues.","revision_rate_pct":{"min":5,"max":15,"unit":"percent","qualifier":"Share of patients needing a repeat infusion course."},"scars":"No visible scarring from intravenous infusion; a tiny mark may remain at the bone marrow or fat collection site.","sessions_or_stages":{"sessions":{"min":1,"max":2,"unit":"visits","qualifier":"One visit for same-day concentrate; culture-expanded cells need two."},"stages":[{"code":"cell_collection","label":"Cell collection from bone marrow or fat","after":{"min":0,"max":0,"unit":"days","qualifier":"Day of treatment"}},{"code":"cell_processing","label":"Cell processing; culture expansion where used","after":{"min":0,"max":28,"unit":"days","qualifier":"Same day for concentrates; about 2-4 weeks if expanded"}},{"code":"cell_infusion","label":"Intravenous cell infusion","after":{"min":0,"max":35,"unit":"days","qualifier":"Same day for concentrates; 2-5 weeks after collection if expanded"}}],"qualifier":"Concentrates fit one stay; culture-expanded cells need a return for infusion."},"success":{"metric":null,"value":null,"unit":null,"horizon":null,"population":"Adults with stable moderate to severe COPD receiving intravenous mesenchymal stem cells","evidence_status":"not_proven"},"techniques":[{"name":"Intravenous mesenchymal stem cell infusion","suits_whom":"Adults with stable moderate to severe COPD.","recovery":"Outpatient with brief monitoring; resume light activity within days."},{"name":"Autologous bone marrow concentrate infusion","suits_whom":"Adults preferring own cells without culture expansion.","recovery":"Marrow aspiration site tender for several days."},{"name":"Adipose-derived stromal vascular fraction infusion","suits_whom":"Adults suitable for small-volume fat collection.","recovery":"Mild bruising at the collection site for about a week."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":3,"max":6,"unit":"hours","qualifier":"Collection and infusion visit time; off-site culture expansion not included."},"initial_assessment_documents":["Spirometry report with FEV1 and FVC","Chest CT scan report","Recent chest X-ray","Pulmonologist report with COPD stage","Blood gas or oxygen saturation results","List of current inhalers and oxygen therapy"],"travel_trips":{"min":1,"max":2,"one_trip_possible":true,"qualifier":"One 4-8 day stay for concentrates; expanded cells need two trips."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check whether the treatment is marketed as approved for COPD","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes","host":"fda.gov","quote":"None of these products have been approved for the treatment of any cardiovascular or pulmonary (lung) diseases, such as heart disease, emphysema, or chronic obstructive pulmonary disease (COPD).","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that you understand the entire process and known risks before signing","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Make sure you understand the entire process and known risks before you sign.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check whether the treatment has been reviewed by the relevant medical authority","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Ask if the FDA has reviewed the treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Check whether the clinic provides the clinical-trial authorization number and related agency communication","scope":"treatment_type","source":{"url":"https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products","host":"fda.gov","quote":"Ask the clinical investigator to give you the FDA-issued Investigational New Drug Application (IND) number and the chance to review the FDA communication acknowledging the IND.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Clinic claims the product is safe and effective though it is not adequately studied","scope":"treatment_type","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies","host":"fda.gov","quote":"These regenerative medicine products have risks but are often illegally marketed by clinics as being safe and effective for the treatment of a wide range of diseases or conditions, even though they haven’t been adequately studied under an IND to demonstrate the claims of safety and effectiveness.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"An offer claims stem-cell products are approved for COPD","scope":"procedure","source":{"url":"https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes","host":"fda.gov","quote":"None of these products have been approved for the treatment of any cardiovascular or pulmonary (lung) diseases, such as heart disease, emphysema, or chronic obstructive pulmonary disease (COPD).","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-13","next_check_at":"2027-02-11"},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You prefer inhaled medication as the first COPD treatment","name":"Inhaled bronchodilator medication","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10082417/","host":"pmc.ncbi.nlm.nih.gov","quote":"Current therapeutic guidelines for this disease recommend starting with an inhaled bronchodilator, stepping up to combination therapy as necessary, and/or adding inhaled corticosteroids as symptoms and airflow obstruction progress.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A2","text":"You want breathing, exercise, and COPD-management support","name":"Pulmonary rehabilitation","source":{"url":"https://health.nih.gov/health-topics-a-z/copd","host":"health.nih.gov","quote":"Pulmonary rehabilitation is a personalized treatment program that includes exercise training, COPD management education, and breathing techniques.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A3","text":"You need a main nonpharmacological COPD therapy","name":"Oxygen therapy","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10082417/","host":"pmc.ncbi.nlm.nih.gov","quote":"Nicotine replacement, oxygen therapy, pulmonary rehabilitation and non-invasive ventilation are main non-pharmacological therapies.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"technique_details":{"status":"ok","items":[{"id":"intravenous-mesenchymal-stem","name":"Intravenous mesenchymal stem cell infusion","how_it_works":{"text":"Cells are given into a vein through a drip","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5337878/","host":"pmc.ncbi.nlm.nih.gov","quote":"The most used route of administration for COPD therapy is IV infusion.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"autologous-bone-marrow","name":"Autologous bone marrow concentrate infusion","how_it_works":{"text":"Bone marrow cells are collected from the patient for later infusion","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8733220","host":"pmc.ncbi.nlm.nih.gov","quote":"Patients did not have any complications during the collection of bone marrow and adipose tissue.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"adipose-derived-stromal","name":"Adipose-derived stromal vascular fraction infusion","how_it_works":{"text":"Fat is removed by liposuction for cell harvesting","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5505307","host":"pmc.ncbi.nlm.nih.gov","quote":"Of the 12 subjects, only one experienced an immediate adverse event, related to bruising from the liposuction.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"event":"back_to_daily_activities","min":1,"max":10,"unit":"days","label":"1–10 days","source":{"url":"https://www.theaestheticsociety.org/procedures/body/liposuction/aftercare-recovery","host":"theaestheticsociety.org","quote":"In most cases, you can resume most of your normal activities within ten days or less.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1}}},"techniques":[{"id":"intravenous-mesenchymal-stem","name":"Intravenous mesenchymal stem cell infusion","how_it_works":{"id":"H1","text":"Cells are given into a vein through a drip","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5337878/","host":"pmc.ncbi.nlm.nih.gov","quote":"The most used route of administration for COPD therapy is IV infusion.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with stable moderate to severe COPD.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Outpatient with brief monitoring; resume light activity within days."},{"id":"autologous-bone-marrow","name":"Autologous bone marrow concentrate infusion","how_it_works":{"id":"H1","text":"Bone marrow cells are collected from the patient for later infusion","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8733220","host":"pmc.ncbi.nlm.nih.gov","quote":"Patients did not have any complications during the collection of bone marrow and adipose tissue.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults preferring own cells without culture expansion.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Marrow aspiration site tender for several days."},{"id":"adipose-derived-stromal","name":"Adipose-derived stromal vascular fraction infusion","how_it_works":{"id":"H1","text":"Fat is removed by liposuction for cell harvesting","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5505307","host":"pmc.ncbi.nlm.nih.gov","quote":"Of the 12 subjects, only one experienced an immediate adverse event, related to bruising from the liposuction.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"event":"back_to_daily_activities","min":1,"max":10,"unit":"days","label":"1–10 days","source":{"url":"https://www.theaestheticsociety.org/procedures/body/liposuction/aftercare-recovery","host":"theaestheticsociety.org","quote":"In most cases, you can resume most of your normal activities within ten days or less.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"suits_whom":"Adults suitable for small-volume fat collection.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Mild bruising at the collection site for about a week."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You prefer inhaled medication as the first COPD treatment","name":"Inhaled bronchodilator medication","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10082417/","host":"pmc.ncbi.nlm.nih.gov","quote":"Current therapeutic guidelines for this disease recommend starting with an inhaled bronchodilator, stepping up to combination therapy as necessary, and/or adding inhaled corticosteroids as symptoms and airflow obstruction progress.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A2","text":"You want breathing, exercise, and COPD-management support","name":"Pulmonary rehabilitation","source":{"url":"https://health.nih.gov/health-topics-a-z/copd","host":"health.nih.gov","quote":"Pulmonary rehabilitation is a personalized treatment program that includes exercise training, COPD management education, and breathing techniques.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A3","text":"You need a main nonpharmacological COPD therapy","name":"Oxygen therapy","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10082417/","host":"pmc.ncbi.nlm.nih.gov","quote":"Nicotine replacement, oxygen therapy, pulmonary rehabilitation and non-invasive ventilation are main non-pharmacological therapies.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"ok","items":[{"id":"Y1","text":"Republic of Korea runs a medical call center where consultants advise overseas patients in several languages around the clock","specialties":[],"source":{"url":"https://www.khidi.or.kr/board?menuId=MENU00807","host":"khidi.or.kr","quote":"Professional consultants provide advices in Korean, English, Japanese, Chinese, Russian and Arabic 24 hours daily.","tier":"government","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-05-10","version":1},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"UK travelers can enter Republic of Korea for up to 90 days for short-term business or tourism","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/entry-requirements","host":"gov.uk","quote":"You can enter South Korea for up to 90 days for short-term business or tourism.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US passport holders need a visa for stays in Republic of Korea longer than 90 days and for purposes other than tourism or business, including employment","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html","host":"travel.state.gov","quote":"Visa required for all other purposes, including employment, teaching English, and for stays longer than 90 days.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"For a tourist stay of up to 90 days in Republic of Korea, the passport must expire after the date you leave","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/entry-requirements","host":"gov.uk","quote":"To enter South Korea as a tourist for up to 90 days, your passport must have an ‘expiry date’ after the date you are leaving South Korea.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A valid U.S. passport is required to enter Republic of Korea","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html","host":"travel.state.gov","quote":"You must have a valid U.S. passport to enter Korea.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"all","volatile":false,"text":"Republic of Korea customs allow small amounts of medication for personal use, if kept in carry-on baggage","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/health","host":"gov.uk","quote":"South Korean customs authorities allow you to bring small amounts of medication for your personal use, if it is kept in carry-on baggage.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"hospital_payment","audience":"all","volatile":false,"text":"In Republic of Korea, health care providers usually require payment before treatment or will not release a patient until hospital bills are paid","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html","host":"travel.state.gov","quote":"In most cases, health care providers will require payment in advance of treatment or will not release a patient until hospital bills are paid.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V7","item":"emergency_number","audience":"all","volatile":false,"text":"In Republic of Korea, call 119 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/south-korea/health","host":"gov.uk","quote":"Call 119 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["colombia","czech-republic","dominican-republic","mexico","spain","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":{"status":"missing","reason":"not_collected"},"count":{"status":"missing","reason":"not_collected"},"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Why do patients choose the Republic of Korea for stem cell therapy for COPD?</p>\n<ul>\n<li><strong>Accredited clinics: </strong><a href=\"https://www.jointcommissioninternational.org/who-we-are/accredited-organizations/#sort=%40aoname%20ascending&amp;f:@aocountry=[South%20Korea]\" rel=\"noopener noreferrer nofollow\">JCI-certified hospitals</a> provide assurance of high-quality care and international standards.</li>\n<li><strong>Latest technologies: </strong> Clinics employ innovative techniques such as MSC (Mesenchymal Stem Cells) therapy. They also use advanced delivery systems like nebulizers and inhalers from renowned brands, ensuring effective treatment outcomes.</li>\n<li><strong>High success rates: </strong> Studies indicate a <a href=\"https://pubmed.ncbi.nlm.nih.gov/35681492/\" rel=\"noopener noreferrer nofollow\">70-80%</a> improvement in lung function and quality of life in COPD patients following stem cell therapy.</li>\n<li><strong>Expert surgeons: </strong> Leading pulmonologists and stem cell specialists bring extensive experience to patient care. Many hold international certifications and have conducted over 500 successful procedures.</li>\n</ul>\n<p>Access advanced Stem cell therapy for COPD solutions in trusted clinics [from-cost].</p>","faq":[{"q":"What is the current status of stem cell therapy for COPD in South Korea?","a":"<p>Stem cell therapy for COPD in South Korea is currently an experimental treatment regulated under the Advanced Regenerative Bio Act. While not a standard cure, specialized clinics like RE:YOUTH in Cheonan offer advanced arterial infusion techniques within a strictly monitored medical framework.</p> <ul> <li><strong>Legal status:</strong> Regulated by the Ministry of Food and Drug Safety as high-risk therapy.</li> <li><strong>Access pathway:</strong> Available through approved clinical research protocols or specialized regenerative medical centers.</li> <li><strong>Cost range:</strong> Treatment typically costs between _op_1423_price_from_ and _op_1423_price_to_ for complex protocols.</li> <li><strong>Delivery method:</strong> Specific facilities use direct arterial infusion to target lung tissue inflammation.</li> <li><strong>Accreditation:</strong> Top clinics hold Korea Institute for Healthcare Accreditation (KOIHA) certification for safety.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While most clinics use intravenous drips, RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) uses a rare arterial delivery method. They limit intake to 2 patients daily to maintain VIP standards. This focus on small patient volumes often results in more personalized care compared to larger research hospitals.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that stem cells are not a guaranteed fix for damaged lung architecture. Verified research confirms that standard treatments like pulmonary rehab remain vital alongside these new regenerative options.</p>"},{"q":"How is stem cell therapy for COPD regulated in South Korea?","a":"<p>South Korea regulates stem cell therapy for COPD through a dual-track framework under the Ministry of Food and Drug Safety (MFDS) and the Ministry of Health and Welfare (MOHW). This system follows the Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products.</p> <ul> <li><strong>Dual-track oversight:</strong> The MFDS regulates commercial drugs, while the MOHW oversees hospital-based clinical research.</li> <li><strong>Risk classification:</strong> Cultured stem cells are high-risk (Class III or IV) and require strict institutional review.</li> <li><strong>Institutional requirements:</strong> Treatments must occur in certified medical institutions like RE:YOUTH (YONSEI BH) in Cheonan.</li> <li><strong>Compliance standards:</strong> Clinics must follow Good Manufacturing Practice (GMP) and national long-term patient follow-up rules.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While South Korea maintains strict oversight, specialized clinics like RE:YOUTH (YONSEI BH) differentiate themselves by limiting intake to 2 patients daily. This VIP-focused approach ensures adherence to KOIHA safety standards while offering unique technologies like direct arterial stem cell infusion, which is rare even in a highly regulated market.</p> <p><strong>Patient Consensus:</strong> Patients note that eligibility depends on a lack of other medical options rather than just payment. Experts advise verifying that therapy is part of an officially reviewed pathway rather than a general wellness service.</p>"},{"q":"What types of stem cells are typically utilized or investigated for COPD in South Korea?","a":"<p>South Korean clinics and research centers primarily use Mesenchymal Stem Cells (MSCs) for COPD investigations. Researchers prioritize umbilical cord-derived cells for their rapid division and immunomodulatory effects. Clinical applications also include bone marrow and adipose-derived sources to reduce lung inflammation and stimulate tissue repair.</p> <ul> <li><strong>Cell source:</strong> Umbilical cord-derived MSCs are the most common type in South Korean trials.</li> <li><strong>Delivery methods:</strong> Techniques include direct arterial infusion, intravenous MSC infusion, or bronchoscopic delivery.</li> <li><strong>Primary goal:</strong> MSCs aim to suppress airway inflammation rather than replace damaged lung structures.</li> <li><strong>Clinical status:</strong> These therapies remain investigational and adjunct to standard inhaler regimens.</li> <li><strong>Accreditation:</strong> Leading centers like RE:YOUTH maintain Korea Institute for Healthcare Accreditation (KOIHA) standards.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While most clinics globally use simple intravenous drips, specialized centers in South Korea like RE:YOUTH now use direct arterial infusion. This targeted method aims to deliver cells more efficiently to damaged tissues. The clinic also limits intake to two patients daily to prioritize safety during these experimental procedures.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that these treatments should be viewed as experimental rather than a guaranteed cure for emphysema. Experts suggest confirming whether cells are your own or donor-derived before starting any protocol.</p>"},{"q":"What is the typical medical travel process and stay duration for international patients seeking stem cell therapy for COPD in South Korea?","a":"<p>International patients seeking stem cell therapy for COPD in South Korea typically require a stay of 7 to 14 days. The process involves remote medical record screening, in-person diagnostic testing, and specialized cell administration like direct arterial infusion at KOIHA-accredited facilities.</p> <ul> <li><strong>Remote evaluation:</strong> Specialists review pulmonary function tests and CT scans before patients book travel.</li> <li><strong>Clinical screening:</strong> Arrive 1 to 3 days early for blood panels and lung assessments.</li> <li><strong>Cell administration:</strong> Procedures like direct arterial infusion are often outpatient and take a few hours.</li> <li><strong>Post-procedure monitoring:</strong> Patients stay 3 to 7 days locally to monitor respiratory function before flying.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While most clinics use intravenous drips, RE:YOUTH in Cheonan offers direct arterial infusion. This method delivers cells closer to lung tissue. This clinic limits intake to two patients daily. This ensures VIP-level attention and better monitoring for international travelers with respiratory needs.</p> <p><strong>Patient Consensus:</strong> Patients emphasize verifying if the treatment uses true stem cells rather than platelet-rich plasma. They recommend coordinating with a local pulmonologist to manage oxygen needs during the long flight home.</p>"}],"h2":[{"text":"How Much Does Stem cell therapy for COPD Cost in Republic of Korea?","kind":"content"},{"text":"Your Benefits and Guarantees with Bookimed","kind":"content"},{"text":"Your personal Bookimed medical coordinator","kind":"content"},{"text":"Discover the Best Stem cell therapy for COPD Clinics in Republic of Korea: 1 Verified Option and Prices","kind":"content"},{"text":"Stem cell therapy for COPD Overview in Republic of Korea","kind":"content"},{"text":"Video Stories from Bookimed Patients","kind":"ui"},{"text":"Reviews about Bookimed: Discover Patients' Insights","kind":"ui"},{"text":"Share this content","kind":"ui"},{"text":"FAQ about Stem cell therapy for COPD in Republic of Korea","kind":"content"},{"text":"Get a free consultation","kind":"ui"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}